Clinical bacteriology in low-resource settings : today's solutions
Copyright © 2018 Elsevier Ltd. All rights reserved..
Low-resource settings are disproportionately burdened by infectious diseases and antimicrobial resistance. Good quality clinical bacteriology through a well functioning reference laboratory network is necessary for effective resistance control, but low-resource settings face infrastructural, technical, and behavioural challenges in the implementation of clinical bacteriology. In this Personal View, we explore what constitutes successful implementation of clinical bacteriology in low-resource settings and describe a framework for implementation that is suitable for general referral hospitals in low-income and middle-income countries with a moderate infrastructure. Most microbiological techniques and equipment are not developed for the specific needs of such settings. Pending the arrival of a new generation diagnostics for these settings, we suggest focus on improving, adapting, and implementing conventional, culture-based techniques. Priorities in low-resource settings include harmonised, quality assured, and tropicalised equipment, consumables, and techniques, and rationalised bacterial identification and testing for antimicrobial resistance. Diagnostics should be integrated into clinical care and patient management; clinically relevant specimens must be appropriately selected and prioritised. Open-access training materials and information management tools should be developed. Also important is the need for onsite validation and field adoption of diagnostics in low-resource settings, with considerable shortening of the time between development and implementation of diagnostics. We argue that the implementation of clinical bacteriology in low-resource settings improves patient management, provides valuable surveillance for local antibiotic treatment guidelines and national policies, and supports containment of antimicrobial resistance and the prevention and control of hospital-acquired infections.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 18(2018), 8 vom: 15. Aug., Seite e248-e258 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ombelet, Sien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.04.2019 Date Revised 09.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(18)30093-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM281764190 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM281764190 | ||
| 003 | DE-627 | ||
| 005 | 20231225032403.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(18)30093-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0939.xml |
| 035 | |a (DE-627)NLM281764190 | ||
| 035 | |a (NLM)29519767 | ||
| 035 | |a (PII)S1473-3099(18)30093-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ombelet, Sien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical bacteriology in low-resource settings |b today's solutions |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.04.2019 | ||
| 500 | |a Date Revised 09.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2018 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Low-resource settings are disproportionately burdened by infectious diseases and antimicrobial resistance. Good quality clinical bacteriology through a well functioning reference laboratory network is necessary for effective resistance control, but low-resource settings face infrastructural, technical, and behavioural challenges in the implementation of clinical bacteriology. In this Personal View, we explore what constitutes successful implementation of clinical bacteriology in low-resource settings and describe a framework for implementation that is suitable for general referral hospitals in low-income and middle-income countries with a moderate infrastructure. Most microbiological techniques and equipment are not developed for the specific needs of such settings. Pending the arrival of a new generation diagnostics for these settings, we suggest focus on improving, adapting, and implementing conventional, culture-based techniques. Priorities in low-resource settings include harmonised, quality assured, and tropicalised equipment, consumables, and techniques, and rationalised bacterial identification and testing for antimicrobial resistance. Diagnostics should be integrated into clinical care and patient management; clinically relevant specimens must be appropriately selected and prioritised. Open-access training materials and information management tools should be developed. Also important is the need for onsite validation and field adoption of diagnostics in low-resource settings, with considerable shortening of the time between development and implementation of diagnostics. We argue that the implementation of clinical bacteriology in low-resource settings improves patient management, provides valuable surveillance for local antibiotic treatment guidelines and national policies, and supports containment of antimicrobial resistance and the prevention and control of hospital-acquired infections | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Ronat, Jean-Baptiste |e verfasserin |4 aut | |
| 700 | 1 | |a Walsh, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Yansouni, Cedric P |e verfasserin |4 aut | |
| 700 | 1 | |a Cox, Janneke |e verfasserin |4 aut | |
| 700 | 1 | |a Vlieghe, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Martiny, Delphine |e verfasserin |4 aut | |
| 700 | 1 | |a Semret, Makeda |e verfasserin |4 aut | |
| 700 | 1 | |a Vandenberg, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobs, Jan |e verfasserin |4 aut | |
| 700 | 0 | |a Bacteriology in Low Resource Settings working group |e verfasserin |4 aut | |
| 700 | 1 | |a Lunguya, Octavie |e investigator |4 oth | |
| 700 | 1 | |a Phoba, Marie-France |e investigator |4 oth | |
| 700 | 1 | |a Lompo, Palpouguini |e investigator |4 oth | |
| 700 | 1 | |a Phe, Thong |e investigator |4 oth | |
| 700 | 1 | |a Kariuki, Samuel |e investigator |4 oth | |
| 700 | 1 | |a Newton, Paul N |e investigator |4 oth | |
| 700 | 1 | |a Dance, David A B |e investigator |4 oth | |
| 700 | 1 | |a Muvunyi, Claude |e investigator |4 oth | |
| 700 | 1 | |a El Safi, Sayda |e investigator |4 oth | |
| 700 | 1 | |a Barbe, Barbara |e investigator |4 oth | |
| 700 | 1 | |a Falay, Dadi |e investigator |4 oth | |
| 700 | 1 | |a Affolabi, Dissou |e investigator |4 oth | |
| 700 | 1 | |a Page, Maurice |e investigator |4 oth | |
| 700 | 1 | |a Langendorf, Céline |e investigator |4 oth | |
| 700 | 1 | |a Gille, Yves |e investigator |4 oth | |
| 700 | 1 | |a Leenstra, Tjalling |e investigator |4 oth | |
| 700 | 1 | |a Stelling, John |e investigator |4 oth | |
| 700 | 1 | |a Naas, Thierry |e investigator |4 oth | |
| 700 | 1 | |a Kesteman, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Seifu, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Delarocque-Astagneau, Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Schultsz, Constance |e investigator |4 oth | |
| 700 | 1 | |a Schutt-Gerowitt, Heidi |e investigator |4 oth | |
| 700 | 1 | |a Letchford, Joanne |e investigator |4 oth | |
| 700 | 1 | |a Wertheim, Heiman |e investigator |4 oth | |
| 700 | 1 | |a Kahlmeter, Gunnar |e investigator |4 oth | |
| 700 | 1 | |a Aidara Kane, Awa |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 18(2018), 8 vom: 15. Aug., Seite e248-e258 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2018 |g number:8 |g day:15 |g month:08 |g pages:e248-e258 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(18)30093-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2018 |e 8 |b 15 |c 08 |h e248-e258 | ||